365 related articles for article (PubMed ID: 17109521)
1. Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization.
Kim DY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Shin SW; Choo SW; Do YS; Rhee JC
World J Gastroenterol; 2006 Nov; 12(43):6992-7. PubMed ID: 17109521
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
3. Transarterial Chemoembolization Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma.
Hołówko W; Wróblewski T; Wojtaszek M; Grąt M; Kobryń K; Ziarkiewicz-Wróblewska B; Krawczyk M
Ann Transplant; 2015 Dec; 20():764-8. PubMed ID: 26712800
[TBL] [Abstract][Full Text] [Related]
4. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?
Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP
J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach?
Sotiropoulos GC; Drühe N; Sgourakis G; Molmenti EP; Beckebaum S; Baba HA; Antoch G; Hilgard P; Radtke A; Saner FH; Nadalin S; Paul A; Malagó M; Broelsch CE; Lang H
Dig Dis Sci; 2009 Oct; 54(10):2264-73. PubMed ID: 19057997
[TBL] [Abstract][Full Text] [Related]
6. Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?
Kim JM; Kwon CH; Joh JW; Kim SJ; Shin M; Kim EY; Moon JI; Jung GO; Choi GS; Lee SK
Transplant Proc; 2010 Apr; 42(3):821-4. PubMed ID: 20430181
[TBL] [Abstract][Full Text] [Related]
7. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
[TBL] [Abstract][Full Text] [Related]
8. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.
Otto G; Herber S; Heise M; Lohse AW; Mönch C; Bittinger F; Hoppe-Lotichius M; Schuchmann M; Victor A; Pitton M
Liver Transpl; 2006 Aug; 12(8):1260-7. PubMed ID: 16826556
[TBL] [Abstract][Full Text] [Related]
9. Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Kim HD; Shim JH; Kim GA; Shin YM; Yu E; Lee SG; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
J Hepatol; 2015 May; 62(5):1076-84. PubMed ID: 25529626
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation.
Nicolini D; Svegliati-Baroni G; Candelari R; Mincarelli C; Mandolesi A; Bearzi I; Mocchegiani F; Vecchi A; Montalti R; Benedetti A; Risaliti A; Vivarelli M
World J Gastroenterol; 2013 Sep; 19(34):5622-32. PubMed ID: 24039354
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.
Bargellini I; Vignali C; Cioni R; Petruzzi P; Cicorelli A; Campani D; De Simone P; Filipponi F; Bartolozzi C
Radiology; 2010 Apr; 255(1):289-300. PubMed ID: 20308465
[TBL] [Abstract][Full Text] [Related]
13. Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation?
Allard MA; Sebagh M; Ruiz A; Guettier C; Paule B; Vibert E; Cunha AS; Cherqui D; Samuel D; Bismuth H; Castaing D; Adam R
J Hepatol; 2015 Jul; 63(1):83-92. PubMed ID: 25646884
[TBL] [Abstract][Full Text] [Related]
14. [TACE: therapy of the HCC before liver transplantation--experiences].
Herber S; Schneider J; Brecher B; Höhler T; Thelen M; Otto G; Pitton MB
Rofo; 2005 May; 177(5):681-90. PubMed ID: 15871083
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
Zhang DZ; Wei XD; Wang XP
World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
[TBL] [Abstract][Full Text] [Related]
16. Are There Upper Limits in Tumor Burden for Down-Staging of Hepatocellular Carcinoma to Liver Transplant? Analysis of the All-Comers Protocol.
Sinha J; Mehta N; Dodge JL; Poltavskiy E; Roberts J; Yao F
Hepatology; 2019 Oct; 70(4):1185-1196. PubMed ID: 30779440
[TBL] [Abstract][Full Text] [Related]
17. Survival advantage of radiofrequency ablation over transarterial chemoembolization for patients with hepatocellular carcinoma and good performance status within the Milan criteria.
Liu PH; Lee YH; Hsu CY; Huang YH; Chiou YY; Lin HC; Huo TI
Ann Surg Oncol; 2014 Nov; 21(12):3835-43. PubMed ID: 24903236
[TBL] [Abstract][Full Text] [Related]
18. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.
Decaens T; Roudot-Thoraval F; Bresson-Hadni S; Meyer C; Gugenheim J; Durand F; Bernard PH; Boillot O; Boudjema K; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Dharancy S; Chazouilleres O; Dhumeaux D; Cherqui D; Duvoux C
Liver Transpl; 2005 Jul; 11(7):767-775. PubMed ID: 15973710
[TBL] [Abstract][Full Text] [Related]
19. Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis.
Seehofer D; Nebrig M; Denecke T; Kroencke T; Weichert W; Stockmann M; Somasundaram R; Schott E; Puhl G; Neuhaus P
Clin Transplant; 2012; 26(5):764-74. PubMed ID: 22432589
[TBL] [Abstract][Full Text] [Related]
20. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
